Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices 7095 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–01693 Filed 1–25–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21CG; Docket No. CDC–2021– 

0004] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled A Longitudinal Examination of 

Mental and Physical Health among 

Police Associated with COVID–19. The 

aim of this project is to evaluate the 

longitudinal consequences of the 

COVID–19 pandemic on the mental and 

physical health of police officers. 

DATES: CDC must receive written 

comments on or before March 29, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0004 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

A Longitudinal Examination of 

Mental and Physical Health among 

Police Associated with COVID–19— 

New—National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Police officers are exposed to several 

stressors during their working lives, 

including traumatic events (e.g., motorvehicle accidents, domestic incidents), 

organizational stressors (e.g., long work 

hours, shiftwork), public criticism, and 

concern about physical harm. On top of 

these day-to-day stressors, the 

coronavirus disease 2019 (COVID–19) 

has contributed to an increase in mental 

and physical risk. Although exact 

figures are not known, in April 2020, it 

was estimated that approximately 17% 

of the New York police department were 

out sick and five officers had died. Over 

1000 police officers had tested positive 

for COVID–19. Since then, rates of 

COVID–19 have not only increased in 

the general population, but also in 

police populations. These preliminary 

studies indicate that police departments 

are under a great deal of stress and at 

greater risk because of COVID–19. Given 

that efficiently performing officers are 

key to successful functioning of law 

enforcement, addressing police mental 

and physical health is imperative for 

their well-being, as well as that of the 

public they serve. Nonetheless, little 

research has been conducted to evaluate 

the physical and mental health 

consequences of the COVID–19 

pandemic on police officers. Thus, 

NIOSH seeks OMB approval to evaluate 

the longitudinal mental and physical 

health effect of the COVID–19 pandemic 

on police officers. 

Previously, in collaboration with 

NIOSH, the University of New York at 

Buffalo (UB) conducted a cross-sectional 

research project to evaluate the mental, 

physical, and subclinical measures of 

health in Buffalo, NY police officers as 

part of the Buffalo Cardio-Metabolic 

Occupational Police Stress (BCOPS) 

study. The BCOPs study itself includes 

a baseline examination and four followup examinations. For this reason, 

NIOSH has mental and physical health 

data on police officers collected prior to 

COVID–19, including stress related 

surveys, blood parameters, physical 

measures, stress biomarkers (cortisol) 

and telomere length data. 

To meet the aims of the current study 

NIOSH has contracted with UB to 

recruit 200 police officers who 

previously participated in a BCOPS 

study. Priority will be placed on 

recruiting officers who participated in 

the last BCOPS study (n=240). If 200 of 

the 240 officers cannot be recruited, 

then UB will try to recruit any officer 

who has previously participated in a 

BCOPS study. A subset of the surveys 

and biological data collected as part of 

the BCOPS studies will be repeated for 

this study. By comparing the responses 

of the surveys and physical data 

collected as part of BCOPS, prior to 

COVID–19, to those obtained during this 

study, NIOSH can evaluate the 

longitudinal physical and psychological 

7096 Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices 

health effects of COVID–19 on the 

police officers. 

To meet the aims of this study there 

will be two rounds of data collection. 

The first round will consist of collecting 

both the mental and physical health 

data. The second round, approximately 

6–8 months later, will consist of 

collecting the mental health and 

medical history surveys only. 

During the first round, letters will be 

sent to officers who participated in the 

previous BCOPS study asking them to 

voluntarily participate in this study. 

Once they agree, a letter of introduction 

will be sent. If an officer hasn’t 

responded after two letters have been 

sent, UB will contact the officers by 

phone. If the officer declines to 

participate they will no longer be 

contacted. For officers who agree to 

participate, UB will coordinate the 

scheduling of officers with the police 

department and will not schedule 

officers more than one month in 

advance. Scheduling will be flexible. 

At their designated appointment, all 

participants will complete the paper 

and pencil questionnaires then 

complete the clinical exam, which will 

entail a fasting blood draw 

(approximately four tablespoons), 

measuring the participants’ height, 

weight, abdominal height, waist 

circumference and neck circumference, 

and taking their blood pressure. Cortisol 

saliva testing will be done outside of the 

clinic at the participant’s residence by 

the participant. Participants will be 

provided with Salivettes (Sarstedt, 

USA), a commercially available 

collection device consisting of dental 

rolls and centrifuge tubes, to take with 

them when the leave the clinic for the 

collection of saliva samples. 

Participants will be given instructions 

on how to collect the samples to be 

taken the day after they leave the 

clinic—four samples in the morning 

when they awaken, one at lunchtime, 

one at dinner, and one when the go to 

sleep. The participant will be asked to 

return the saliva samples to the clinic 

when completed either in person or via 

paid postage. This ends the clinic visit. 

UB will advise the participant upon 

departing during round one that they 

would like to contact them again in 

about 6–8 months to complete the same 

surveys they did in the clinic. 

For the second round, UB will 

conduct a follow-up survey 

approximately 6–8 months after the 

clinic visit. Each officer who 

participated in the first round and who 

agreed to participate in the second 

round, will be sent the same set of 

psychological surveys, the medical 

history questionnaire, and a follow-up 

COVID questionnaire. The 

psychological surveys will be the same 

surveys they did during the first round, 

while the COVID questionnaire asks 

additional questions related to their 

experience with COVID since the clinic 

visit. They will not be asked to complete 

the personal history questionnaire the 

second time. This second set of 

questionnaires allows NIOSH to meet 

the study aims. 

The burden table lists the estimated 

population size of 200 police officers 

who will respond to 16 psychosocial 

questionnaires, serological (blood) 

collection, and salivary cortisol at the 

first round. All officers who participate 

in the first round and who have agreed, 

will be mailed the medical history 

questionnaire and psychosocial 

questionnaires 6–8 months later (second 

round). Biological samples will not be 

collected during the second round. We 

anticipate that up to 10% of the 

participants may not present for testing 

during either the first round or second 

round of questionnaires. Therefore, we 

estimate that 180 officers will complete 

both rounds of the data collection. The 

total burden hours for all surveys, 

serological sample collection, and 

salivary cortisol is 547. There are no 

costs to the respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Police officers ......... Personal history .......................................................... 180 1 2/60 6 

Medical history ............................................................ 180 2 8/60 48 

Spielberger Stress Survey .......................................... 180 2 7/60 42 

Center for Epidemiologic Studies Depression Scale .. 180 2 2/60 12 

Brief Cope ................................................................... 180 2 3/60 18 

Organizational Support Scale ..................................... 180 2 2/60 12 

Maslach Burnout ......................................................... 180 2 2/60 12 

Fatigue Scale .............................................................. 180 2 2/60 12 

Posttraumatic Stress Disorder –5 ............................... 180 2 2/60 12 

Connor-Davidson Resiliency Scale ............................. 180 2 1/60 6 

Beck Anxiety ............................................................... 180 2 3/60 18 

Pittsburgh Sleep Quality Index ................................... ........................ 2 2/60 12 

Beck Depression ......................................................... 180 2 3/60 18 

Beck Hopelessness ..................................................... 180 2 2/60 14 

COVID–19 (round 1) ................................................... 180 1 3/60 9 

COVID–19 (round 2) ................................................... 180 1 3/60 9 

Civil Unrest/Public Perception/work environment ....... 180 2 3/60 17 

Serological Sample collection ..................................... 180 1 1 180 

Salivary Cortisol collection .......................................... 180 1 30/60 90 

Total ................ ...................................................................................... ........................ ........................ ........................ 547 

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices 7097 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–01621 Filed 1–25–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-21–21CH; Docket No. CDC–2021– 

0005] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Serological Assay Development: 

Brucella spp. Rough Strains. This 

proposed collection will involve 

specimen collection and relevant 

clinical information from individuals 

exposed to rough strains of Brucella 

spp., or cases of brucellosis due to 

infection with rough strains of Brucella 

spp. 

DATES: CDC must receive written 

comments on or before March 29, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0005 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Serological Assay Development: 

Brucella spp. Rough Strains—New— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Brucellosis is a zoonotic disease 

caused by Brucella spp., which are 

Gram-negative, intracellular bacterial 

pathogens. Annually, 500,000 human 

cases of brucellosis occur worldwide. 

Though isolation of the organism can 

help identify the causative species of 

infection, this method is not always 

possible due to laboratory biosafety 

capacity requirements and specimen 

availability. In some of these instances, 

serological methods are helpful for 

diagnosis. Serial serological methods are 

also useful for monitoring individuals 

who have had known exposures to 

smooth Brucella spp. for 

seroconversion, which can help detect 

potential infection and reduce time to 

diagnosis and treatment. 

The proposed data collection will 

help to understand the frequency of 

exposures to rough strain Brucella spp. 

in the United States, identify specific 

antigens associated with rough strain 

Brucella infections, develop highsensitivity and high-specificity 

serological diagnostic assays based on 

recognition of these antigens, and to 

better understand the human humoral 

immune response to rough Brucella 

strains. Data collected will be used to 

create a bank of specimens to help 

develop additional tools for safer and 

more timely diagnosis of brucellosis 

caused by rough strains of Brucella spp. 

CDC will collect specimens and 

medical/surveillance record abstractions 

from individuals exposed to rough 

strains of Brucella spp., and individuals 

with confirmed diagnosis of brucellosis 

as a result of infection from rough 

strains of Brucella spp. 

CDC requests approval for three years. 

The estimated annualized burden hours 

are 55. There is no cost to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Patient (specimen collection) ............ N/A ................................................... 10 1 5 50